Table 1 Demographics and clinical features of subjects enrolled in the study.
From: Retinal vessels modifications in acute and post-COVID-19
COVID-19 patients n = 32 | Unexposed subjects n = 53 | p value | |
|---|---|---|---|
Age, mean years (SD, range) | 48.4 (13.7, 24–72) | 43.7 (12.6, 25–64) | 0.10* |
Gender, n (%) males | 22 (68.7) | 23 (43.4) | 0.03** |
Ethnicity, n (%) | < 0.0001** | ||
Caucasian | 16 (50.0) | 53 (100) | |
Latin-American | 9 (28.1) | 0 (0) | |
Indian | 6 (18.7) | 0 (0) | |
African | 1 (3.1) | 0 (0) | |
Body mass index (Kg/m2), mean (SD, range) | 26.9 (4.5, 20.2–38.5) | 23.9 (4.3, 17–37.1) | 0.002* |
Comorbidities, n (%) | |||
Systemic hypertension | 8 (25.0) | 9 (16.9) | 0.41** |
Diabetes | 5 (15.6) | 2 (3.8) | 0.09** |
HIV | 1 (3.1) | 0 (0.0) | 0.37** |
TB | 1 (3.1) | 0 (0.0) | 0.37** |
Alcohol consumption | 7 (21.8) | 19 (35.8) | 0.22** |
Smoking | 8 (25) | 15 (28.3) | 0.80** |
Dyslipidemia | 4 (12.5) | 5 (9.4) | 0.72** |
Coronary disease/stroke | 1 (3.1) | 0 (0.0) | 0.37** |
COVID-19 severity, n (%) severe | 11 (34.4) | NA | NA |
